a Refacto tool
AdvertisementYour banner here · 728 × 90 · ads@refacto.app

← Explore · Market KXFDAAPPROVE-MDMA-29JAN01

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2029?

53.0% implied · bid 50.0¢ · ask 56.0¢

☆ Log in to track

A · Price & probability

The market prices this at 51.0%, up 0.0pt over 24h, on a 6.0¢ spread.

Implied probability51.0%
Bid / ask / mid50.0¢ / 56.0¢ / 53.0¢
Spread6.0¢ (11.3%)
Change 24h+0.00pt
Change 7d-0.50pt

B · Liquidity & flow

Thin (score 20/100) — trade small; large orders will move the price. Order book leans 22% to the ask (sellers).

Volume 24h$0
Depth ±5¢ (bid/ask)$3 / $280
Imbalance22% bid
Large trades (>$1k)0
Liquidity score20.1 / 100

C · Momentum & volatility

RSI 50 (neutral); price is below its 7-day mean by 1.0σ — a mild deviation.

Z-score vs 7d mean-1.01
RSI (14, hourly)50.0
Realized vol 7d3.05pt
Change 1h+0.00pt

E · Time & structure

Resolves in 1945d 6h.

Time to resolve1945d 6h
Resolution sourcemanual-review
Sum of outcomes100.0%

Price history

Probability timeline

Order-book depth